Genetic evidence against the 16S ribosomal RNA helix 27 conformational switch model.
A mechanistic understanding of ribosome function demands knowledge of the conformational changes that occur during protein synthesis. One current model proposes a conformational switch in Helix 27 (H27) of 16S rRNA involved in the decoding of mRNA. This model was based on the behavior of mutations in the 912 region of H27 of Escherichia coli 16S rRNA, which were predicted to stabilize the helix in either of two alternative conformations. This interpretation was supported by evidence from both genetics and structural biochemistry. However, recently published X-ray crystallographic structures of the Thermus thermophilus 30S subunit at different stages of tRNA selection have raised doubts regarding the validity of this model. We have therefore revisited the model genetically by constructing a H27 quadruple mutation (C912G, C910G, G885C, and G887C), which would create multiple mismatches in the proposed alternative conformation without perturbing the native H27 conformation seen in the crystal structures. Inconsistent with the H27 switch model, cells containing pure populations of quadruple mutant ribosomes grow at essentially wild-type rates. The mutants used to construct the H27 switch model all carried A2058G in 23S rRNA and C1192U in 16S rRNA as selectable markers. The quadruple mutant carrying these additional marker mutations is deleterious, and we conclude that they have a synergistic effect when combined with other mutations and are not phenotypically silent. Their presence confounded the interpretation of the original mutant phenotypes and, in light of the viability of the quadruple mutant, we conclude that the genetic evidence no longer supports the model.
Rodriguez-Correa
Daniel
D
Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island 02912, USA.
Dahlberg
Albert E
AE
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D018360:Crystallography, X-Ray; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli; D008957:Models, Genetic; D016296:Mutagenesis / Q000187:drug effects; D009154:Mutation; D009690:Nucleic Acid Conformation / Q000187:drug effects; D010641:Phenotype; D011487:Protein Conformation / Q000187:drug effects*; D012329:RNA, Bacterial / Q000737:chemistry* / Q000235:genetics; D012336:RNA, Ribosomal, 16S / Q000187:drug effects / Q000235:genetics*; D012338:RNA, Ribosomal, 23S / Q000235:genetics; D012270:Ribosomes / Q000737:chemistry / Q000235:genetics; D000198:Spectinomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S; D012338:RNA, Ribosomal, 23S; D004917:Erythromycin; D000198:Spectinomycin